| Name: | Atazanavir EP Impurity H |
| Catalogue No. | VL2230009 |
| CAS No. | N/A |
| Molecular Formula | C38H52N6O7 |
| Molecular Weight | 704.87 |
| Status | In-stock |
| IUPAC Name | methyl ((5S,8R,9R,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate |
| Synonyms | S,R,R,S Diasteromer |
| Description | Atazanavir Impurity H / S,R,R,S Diasteromer(CAS No: N/A) or methyl ((5S,8R,9R,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate is an impurity of atazanavir. It is also called protease inhibitors. it is an azapeptide that is used to treat human immunodeficiency virus (HIV) infection in adults. it also acts decreases the risk of spreading HIV disease to others. |
| References | Achenbach, Chad J., et al. “Atazanavir/Ritonavir-Based Combination Antiretroviral Therapy for Treatment of HIV-1 Infection in Adults.” Future Virology, vol. 6, no. 2, Feb. 2011, pp. 157–77, https://doi.org/10.2217/fvl.10.89. |
